Jaffetilchin Investment Partners LLC Grows Holdings in CME Group Inc. (NASDAQ:CME)

Jaffetilchin Investment Partners LLC grew its holdings in CME Group Inc. (NASDAQ:CME) by 21.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,580 shares of the financial services provider’s stock after purchasing an additional 643 shares during the period. Jaffetilchin Investment Partners LLC’s holdings in CME Group were worth $950,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of CME. New Age Alpha Advisors LLC increased its stake in CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 43 shares during the period. Alpine Bank Wealth Management purchased a new stake in CME Group in the first quarter worth $32,000. Knuff & Co LLC purchased a new stake in CME Group in the fourth quarter worth $33,000. Banque Transatlantique SA purchased a new stake in CME Group in the fourth quarter worth $35,000. Finally, Whipplewood Advisors LLC bought a new position in shares of CME Group during the 4th quarter worth $37,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insiders Place Their Bets

In other news, Director Dennis Suskind sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $271.28, for a total value of $271,280.00. Following the completion of the transaction, the director now directly owns 2,915 shares in the company, valued at $790,781.20. This trade represents a 25.54% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Charles P. Carey sold 3,000 shares of the firm’s stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $272.56, for a total value of $817,680.00. Following the completion of the transaction, the director now owns 5,400 shares of the company’s stock, valued at approximately $1,471,824. The trade was a 35.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 13,400 shares of company stock valued at $3,680,610. 0.30% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

CME has been the topic of a number of recent research reports. Bank of America increased their price target on CME Group from $200.00 to $219.00 and gave the stock an “underperform” rating in a research report on Wednesday, April 2nd. Piper Sandler increased their price target on CME Group from $275.00 to $283.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 8th. Royal Bank Of Canada reissued a “sector perform” rating and set a $269.00 price target on shares of CME Group in a research report on Thursday, April 3rd. Raymond James Financial raised CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price target on the stock in a research report on Monday, March 10th. Finally, Oppenheimer increased their price target on CME Group from $282.00 to $300.00 and gave the stock an “outperform” rating in a research report on Wednesday, June 4th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $258.20.

CME Group Price Performance

Shares of CME stock opened at $274.76 on Friday. CME Group Inc. has a 1-year low of $193.17 and a 1-year high of $290.79. The stock’s 50-day moving average is $275.21 and its 200 day moving average is $256.53. The company has a market cap of $99.01 billion, a P/E ratio of 27.64, a PEG ratio of 3.70 and a beta of 0.45. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating analysts’ consensus estimates of $2.61 by $0.19. The company had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter last year, the company earned $2.50 earnings per share. Research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were issued a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.82%. The ex-dividend date of this dividend was Monday, June 9th. CME Group’s dividend payout ratio is presently 50.30%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.